[Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Rhea-AI Filing Summary

Insider awards and holdings reported for Colgate-Palmolive (CL). On 09/11/2025 the reporting person received a restricted stock unit (RSU) award of 3,450 shares that vests in three equal annual installments, and a stock option to buy 23,888 shares with an exercise price of $84.06. The option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the grant and expires on 09/11/2033.

Following the reported transactions the reporting person beneficially owned 16,062 shares directly and 8,004 shares indirectly through the issuer's 401(k) plan trustee. The report was signed by an attorney-in-fact on 09/12/2025.

Positive

• RSU award of 3,450 shares granted with explicit three‑year vesting schedule
• Stock option for 23,888 shares disclosed with exercise price $84.06 and defined vesting/exercise timeline
• Beneficial ownership levels clearly stated: 16,062 shares direct and 8,004 shares indirect

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine executive compensation grants; no immediate financial statement metrics changed.

The filing documents a standard equity-based compensation package: a time‑vesting RSU award and a multi‑year option grant with a defined exercise price and expiration. The grant increases the reporting person's direct and indirect beneficial ownership to the levels shown, and creates potential future share issuance if options are exercised or RSUs vest. The information is procedural and typical for senior officers.

Compensation/HR Specialist

TL;DR: Grants follow common retention structure with three‑year vesting schedules for both RSUs and options.

The RSU vests in equal thirds over three years and the option vests annually over three years beginning one year after grant, aligning with standard retention incentives. Key contract terms disclosed are the 23,888 option quantity, $84.06 exercise price, vesting cadence, and RSU quantity of 3,450.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Massey Sally

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		A(1)		3,450	A	$0.0000	16,062	D
Common Stock								8,004	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$84.06	09/11/2025		A(2)		23,888		(3)	09/11/2033	Common Stock	23,888	$0.0000	23,888	D

Explanation of Responses:

1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

2. Stock option award granted under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	09/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards were reported for Colgate-Palmolive (CL)?

The report discloses a 3,450-share RSU award and a 23,888-share stock option with an exercise price of $84.06.

When do the RSUs and options vest for the CL reporting person?

The RSU vests in three equal annual installments. The option vests in equal annual installments over three years beginning on the first anniversary of the 09/11/2025 grant date.

How many Colgate-Palmolive shares does the reporting person own after the transactions?

After the transactions the reporting person beneficially owned 16,062 shares directly and 8,004 shares indirectly (via the issuer's 401(k) plan trustee).

What is the option expiration date reported in the Form 4 for CL?

The option expires on 09/11/2033 as stated in the filing.

Who signed the Form 4 filing for the reporting person?

The filing was signed by /s/ Kristine Hutchinson, Attorney-in-Fact on 09/12/2025.